menu search

Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October

Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced presentations featuring results from […] The post Ocuphire Pharma to Present at Euretina and Retina Society Confere... Read More
Posted: Oct 6 2023, 12:00
Author Name: forextv
Views: 082778

Search within

Pages Search Results: